A detailed history of Exchange Traded Concepts, LLC transactions in Amgen Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 7,206 shares of AMGN stock, worth $2.32 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,206
Previous 2,486 189.86%
Holding current value
$2.32 Million
Previous $706,000 218.84%
% of portfolio
0.06%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $1.24 Million - $1.51 Million
4,720 Added 189.86%
7,206 $2.25 Million
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $3,764 - $4,543
-14 Reduced 0.56%
2,486 $706,000
Q4 2023

Jan 05, 2024

SELL
$255.7 - $288.46 $14.1 Million - $15.9 Million
-55,148 Reduced 95.66%
2,500 $720,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $5.09 Million - $6.32 Million
23,272 Added 67.7%
57,648 $15.5 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $5.47 Million - $6.47 Million
-25,526 Reduced 42.61%
34,376 $7.63 Million
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $255,594 - $311,526
1,132 Added 1.93%
59,902 $14.5 Million
Q4 2022

Jan 17, 2023

BUY
$229.03 - $291.01 $7.47 Million - $9.49 Million
32,611 Added 124.66%
58,770 $15.4 Million
Q3 2022

Oct 07, 2022

BUY
$224.46 - $253.15 $6,509 - $7,341
29 Added 0.11%
26,159 $5.9 Million
Q2 2022

Jul 20, 2022

BUY
$230.71 - $256.74 $5.18 Million - $5.76 Million
22,450 Added 610.05%
26,130 $6.36 Million
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $666,800 - $737,655
3,041 Added 475.9%
3,680 $890,000
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $81,938 - $93,771
-412 Reduced 39.2%
639 $144,000
Q3 2021

Oct 18, 2021

SELL
$212.27 - $248.7 $367,863 - $430,997
-1,733 Reduced 62.25%
1,051 $223,000
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $4.44 Million - $4.93 Million
-19,008 Reduced 87.22%
2,784 $679,000
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $4.45 Million - $5.18 Million
20,043 Added 1145.97%
21,792 $5.42 Million
Q4 2020

Jan 19, 2021

SELL
$216.38 - $257.67 $3.12 Million - $3.71 Million
-14,415 Reduced 89.18%
1,749 $402,000
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $158,154 - $175,880
674 Added 4.35%
16,164 $4.11 Million
Q2 2020

Jul 15, 2020

BUY
$197.81 - $242.74 $2.7 Million - $3.32 Million
13,674 Added 752.97%
15,490 $3.65 Million
Q1 2020

Apr 14, 2020

SELL
$182.24 - $241.7 $1.43 Million - $1.89 Million
-7,833 Reduced 81.18%
1,816 $368,000
Q4 2019

Jan 22, 2020

BUY
$189.21 - $243.2 $1.83 Million - $2.35 Million
9,649 New
9,649 $2.33 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.